What are the advantages of neoadjuvant immunotherapy over adjuvant immunotherapy?
Expert Rev Anticancer Ther
.
2022 Jun;22(6):561-563.
doi: 10.1080/14737140.2022.2069097.
Epub 2022 Apr 26.
Author
Marijo Bilusic
1
Affiliation
1
Medical Oncology GU Site Disease Group Lead, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA.
PMID:
35473572
DOI:
10.1080/14737140.2022.2069097
No abstract available
Publication types
Editorial
MeSH terms
Chemotherapy, Adjuvant
Humans
Immunologic Factors
Immunotherapy*
Neoadjuvant Therapy*
Substances
Immunologic Factors